| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2431859C Transgenic and cloned mammals |
| 02/21/2006 | CA2098959C Compounds and methods for the site-specific photoaffinity labelling of biomolecules |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/17/2006 | WO2007032751A2 Isolated fungal promoters and gene transcription terminators and methods of protein and chemical production in a fungus |
| 02/16/2006 | WO2006017853A2 Mutant interleukin-15-containing compositions and suppression of an immune response |
| 02/16/2006 | WO2006017749A2 Optimizing expression of active botulinum toxin type a |
| 02/16/2006 | WO2006017578A2 Peptide sequence for modulation of delta protein kinase c |
| 02/16/2006 | WO2006017386A2 Signaling intermediates in an in vitro model of alzheimer’s disease |
| 02/16/2006 | WO2006017355A2 Improved aprotinin variants |
| 02/16/2006 | WO2006017195A1 Lipidated glycoprotein particles and methods of use |
| 02/16/2006 | WO2006017184A2 HYBRID PROTEINS WITH ErbB4 EXTRACELLULAR DOMAIN AND NEUREGULIN HEPARIN-BINDING DOMAIN FOR TARGETING |
| 02/16/2006 | WO2006016999A1 Methods for identifying factors for differentiating definitive endoderm |
| 02/16/2006 | WO2006016960A2 Method for purifying a protein of the cystine-knot superfamily |
| 02/16/2006 | WO2006016808A2 Means and methods for producing a stabilized cell of interest |
| 02/16/2006 | WO2006016692A1 Knockout nonhuman animal |
| 02/16/2006 | WO2006016282A2 Media indexer |
| 02/16/2006 | WO2006016172A2 Cell surface glycoprotein |
| 02/16/2006 | WO2006016121A1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 02/16/2006 | WO2006015882A2 Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent |
| 02/16/2006 | WO2006015557A1 Recombinant live fowlpox virus vectors and their use in pharmaceutical compositions against hepatitis c virus |
| 02/16/2006 | WO2005119263A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 92 (gpr92) |
| 02/16/2006 | WO2005118630A3 Peptides for the treatment of diabetes |
| 02/16/2006 | WO2005118617A3 Method for the purification of polymers carrying a lipophilic group |
| 02/16/2006 | WO2005116068A8 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/16/2006 | WO2005113572A3 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof |
| 02/16/2006 | WO2005103082A3 Group 1 mite polypeptide variants |
| 02/16/2006 | WO2005097825A3 Bmp-7 variants with improved properties |
| 02/16/2006 | WO2005095624A3 Filamentous fungal mutants with improved homologous recombination efficiency |
| 02/16/2006 | WO2005077095A3 Ccn1 transgenic animals |
| 02/16/2006 | WO2005076012A3 Novel splice variants and methods of use thereof |
| 02/16/2006 | WO2005066633A3 Fluorescent ligands for gpcr arrays |
| 02/16/2006 | WO2005038463A8 Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck) -molecules, corresponding substances and detection reagents |
| 02/16/2006 | WO2005037191A3 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 02/16/2006 | WO2005014791A3 Methods and compositions for targeted cleavage and recombination |
| 02/16/2006 | WO2004106359A3 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals |
| 02/16/2006 | WO2004101600A3 Novel poly(ethylene glycol) modified compounds and uses thereof |
| 02/16/2006 | WO2004096992A3 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 02/16/2006 | WO2004091491A3 Profiling conformational variants, antibody compositions and methods of using the same |
| 02/16/2006 | WO2004083448A3 Molecular differences between species of the m.tuberculosis complex |
| 02/16/2006 | WO2004078936A3 Methods for preventing gluconoylation of proteins |
| 02/16/2006 | WO2004078777A3 Dipeptidyl-peptidase protected proteins |
| 02/16/2006 | WO2004063326A3 Proteorhodopsin mutants with improved optical characteristics |
| 02/16/2006 | WO2004048549A3 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods |
| 02/16/2006 | WO2004048515A3 Streptococcus uberis adhesion molecule |
| 02/16/2006 | WO2004048451A3 Optical information carrier comprising immobilized proteorhodopsin |
| 02/16/2006 | WO2004037986A3 Map2k6 as modifier of branching morphogenensis and methods of use |
| 02/16/2006 | WO2004029199A3 A set of ubiquitous cellular proteins involved in viral life cycle |
| 02/16/2006 | WO2004018697A3 Protease resistant ti-growth hormone releasing hormone |
| 02/16/2006 | WO2003100003A3 Isolated polynucleotides and methods of promoting a morphology in a fungus |
| 02/16/2006 | WO2003093439A3 Enzymes |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003070164A3 Attenuated mycobacterium tuberculosis vaccines |
| 02/16/2006 | WO2003059248A3 Pigment epithelium derived factor from human plasma and methods of use thereof |
| 02/16/2006 | WO2003050293A3 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY |
| 02/16/2006 | WO2003046151A3 Nucleic acid-associated proteins |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | WO2002097394A3 Rhesus monkey, dog and ferret melanin-concentrating hormone type 2 receptor |
| 02/16/2006 | WO2002081639A3 Gene brcc2 and diagnostic and therapeutic uses thereof |
| 02/16/2006 | US20060037109 Alteration of amino acid compositions in seeds |
| 02/16/2006 | US20060037103 Expression vector comprising cytokinin regulatory sequences for use as tool in enhancement of fatty acid and carbohydrate metabolism in plants; spatial and temporal specificity in heterologous gene transcription |
| 02/16/2006 | US20060037102 Sugar and lipid metabolism regulators in plants IV |
| 02/16/2006 | US20060037097 Plant disease resistance genes |
| 02/16/2006 | US20060037094 Secreted protein associated with depression, compositions and methods of use thereof |
| 02/16/2006 | US20060037093 Transgenic transchromosomal rodents for making human antibodies |
| 02/16/2006 | US20060037092 Universal stem cells |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036088 Natural promoters for gene expression in C1 metabolizing bacteria |
| 02/16/2006 | US20060036083 Ribosylated human neutrophil peptide-1or an ADP-ribosylated human neutrophil peptide-1; modified antimicrobial activity compared to alpha defensin lacking ADP-ribosylated or ribosylated residue; altered chemotaxis of T cells, altered neutrophil recruitment |
| 02/16/2006 | US20060036081 Process for the preparation of a von Willebrand (FvW) factor concentrate by chromatography and a FvW concentrate thus obtainable |
| 02/16/2006 | US20060036080 Conjugates of GM-CSF moiety and a polymer |
| 02/16/2006 | US20060036079 Surface protein of Leptospira |
| 02/16/2006 | US20060036078 Fluorescent proteins |
| 02/16/2006 | US20060036077 Gamma secretase substrates and in vitro assays |
| 02/16/2006 | US20060036076 Metalloproteinase-binding proteins |
| 02/16/2006 | US20060036075 Using ion exchange resin |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060036073 Neurotrophic and neuroprotective peptides |
| 02/16/2006 | US20060036072 Short-warp peptide dye conjugate as contrast agent for optical diagnostic |
| 02/16/2006 | US20060036071 Processes for preparing eptifibatide |
| 02/16/2006 | US20060036070 Immunoglobulin a inducing protein and uses therefor |
| 02/16/2006 | US20060035857 Methods and compositions for the diagnosis and treatment of cancer |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035852 Genetic products differentially expressed in tumors and the use thereof |
| 02/16/2006 | US20060035851 Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035835 Novel protein, production and use thereof |
| 02/16/2006 | US20060035833 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035832 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035831 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035830 Anti-angiogenic compositions and methods of use |
| 02/16/2006 | US20060035825 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 02/16/2006 | US20060035824 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
| 02/16/2006 | US20060035823 Isolated fragments of p62 nucleoporin and uses thereof |
| 02/16/2006 | US20060035819 Novel molecule |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |